Jun Wu

Dr. Wu, chairman and managing partner of Cenova Capital, has more than 20 years of experience combining venture capital investment, successful entrepreneurship, management of private and public companies and cutting-edge biomedical research. Prior to Cenova, Dr. Wu co-founded and brought public Shanghai Genomics, a drug development company listed at the Tokyo Stock Exchange. He has made groundbreaking contributions to the field of immuno-oncology and has published more than 30 research papers in leading scientific journals including Science, Nature, Nature Genetics and PNAS. Dr. Wu received his Ph.D. from the University of California, San Francisco and completed his postdoctoral training in immuno-oncology at the Merck Biologics Research Institute.